Insiders · Profile

BRAWLEY OTIS W

Director at Lyell Immunopharma. Filing since 31 Mar 2025. CIK 0001213029

Company

Date

Role

Action

Shares

Amount

Of holding

LYEL Lyell Immunopharma, Inc.

31 Mar 2025

Director

Bought

35,640

$19.96K

opened

1 decision on file.